Duax W L, Swenson D C, Strong P D, Korach K S, McLachlan J, Metzler M
Mol Pharmacol. 1984 Nov;26(3):520-5.
A series of indanyl derivatives of diethylstilbestrol (DES) have recently been identified as inv vivo metabolites of DES. These compounds are of interest because they possess effective uterine estrogen receptor-binding affinity but poor biological activity. The X-ray crystal structures of three of these derivatives were determined and their conformations were compared with those of estradiol and DES. The more active derivatives, indenestrol A (I) and indenestrol B (II) have nearly identical conformations, in which the overall molecule is highly planar, the phenyl ring is twisted out of the plane of the indene rings by approximately 30 degrees, and the distance between the hydroxyl groups is 11.6 A. In the least active derivative, idanestrol (III), the methyl, ethyl, and phenyl substituents were found to be in the same side of the indane ring so that the molecule is constrained to an L-shape. The crystallographically observed conformations of I, II, III, DES, and estradiol, their competative binding affinities, and their in vivo biological activities are consistent with the proposal that the steroid A-ring plays a dominant role in initiating receptor binding while the D-ring orientation relative to the A-ring has a more decisive influence upon activity. The reduction in estrogen receptor-binding affinity and associated reduced activity of III is almost certainly due to its L-shape conformation. The extended conformation of I and II in which both phenolic rings are exposed permitting ready access to both surfaces of either ring probably accounts for the ability of these derivatives to compete so successfully with estradiol for estrogen receptor binding. There are eight different ways in which the molecules of the racemic mixtures of I and II could initiate receptor binding. The reduced biological activity of I and II is probably due to the fact that not all eight binding orientations are compatible with eliciting estrogenic response. Comparison of the observed conformations of I, II, DES, and estradiol suggests that it is the alpha-ring of I and II that minics the steroid A-ring in receptor binding, and that two of the four possible alpha-ring/A-ring matches are most conducive to eliciting hormone activity.
最近,已鉴定出一系列己烯雌酚(DES)的茚满基衍生物是DES的体内代谢产物。这些化合物之所以受到关注,是因为它们具有有效的子宫雌激素受体结合亲和力,但生物活性较差。测定了其中三种衍生物的X射线晶体结构,并将它们的构象与雌二醇和DES的构象进行了比较。活性较高的衍生物茚雌酚A(I)和茚雌酚B(II)具有几乎相同的构象,其中整个分子高度平面化,苯环与茚环平面扭曲约30度,羟基之间的距离为11.6埃。在活性最低的衍生物茚诺雌酚(III)中,发现甲基、乙基和苯基取代基位于茚满环的同一侧,因此分子被限制为L形。I、II、III、DES和雌二醇晶体学观察到的构象、它们的竞争性结合亲和力以及它们的体内生物活性与以下提议一致:甾体A环在启动受体结合中起主导作用,而D环相对于A环的取向对活性有更决定性的影响。III的雌激素受体结合亲和力降低以及相关活性降低几乎肯定是由于其L形构象。I和II的伸展构象中两个酚环都暴露在外,使得可以很容易地接近任何一个环的两个表面,这可能解释了这些衍生物能够如此成功地与雌二醇竞争雌激素受体结合的能力。I和II的外消旋混合物分子有八种不同的方式可以启动受体结合。I和II生物活性降低可能是由于并非所有八种结合取向都与引发雌激素反应相容。I、II、DES和雌二醇观察到的构象比较表明,在受体结合中模仿甾体A环的是I和II的α环,并且四个可能的α环/A环匹配中的两个最有利于引发激素活性。